vs
Side-by-side financial comparison of EXELIXIS, INC. (EXEL) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.
SERVICE CORP INTERNATIONAL is the larger business by last-quarter revenue ($1.1B vs $598.7M, roughly 1.9× EXELIXIS, INC.). EXELIXIS, INC. runs the higher net margin — 40.8% vs 14.3%, a 26.5% gap on every dollar of revenue. On growth, EXELIXIS, INC. posted the faster year-over-year revenue change (5.6% vs 1.7%). EXELIXIS, INC. produced more free cash flow last quarter ($332.4M vs $87.2M). Over the past eight quarters, EXELIXIS, INC.'s revenue compounded faster (18.7% CAGR vs 3.1%).
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.
EXEL vs SCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $598.7M | $1.1B |
| Net Profit | $244.5M | $159.4M |
| Gross Margin | 95.6% | 28.0% |
| Operating Margin | 39.3% | 24.8% |
| Net Margin | 40.8% | 14.3% |
| Revenue YoY | 5.6% | 1.7% |
| Net Profit YoY | 74.8% | 5.3% |
| EPS (diluted) | $0.89 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $598.7M | — | ||
| Q4 25 | $597.8M | $1.1B | ||
| Q3 25 | $568.3M | $1.1B | ||
| Q2 25 | $555.4M | $1.1B | ||
| Q1 25 | $566.8M | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $539.5M | $1.0B | ||
| Q2 24 | $637.2M | $1.0B |
| Q1 26 | $244.5M | — | ||
| Q4 25 | $193.6M | $159.4M | ||
| Q3 25 | $184.8M | $117.5M | ||
| Q2 25 | $159.6M | $122.9M | ||
| Q1 25 | $139.9M | $142.9M | ||
| Q4 24 | — | $151.4M | ||
| Q3 24 | $118.0M | $117.8M | ||
| Q2 24 | $226.1M | $118.2M |
| Q1 26 | 95.6% | — | ||
| Q4 25 | 96.9% | 28.0% | ||
| Q3 25 | 96.6% | 25.1% | ||
| Q2 25 | 96.5% | 25.5% | ||
| Q1 25 | 96.5% | 27.1% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | 96.8% | 24.9% | ||
| Q2 24 | 97.2% | 24.9% |
| Q1 26 | 39.3% | — | ||
| Q4 25 | 39.6% | 24.8% | ||
| Q3 25 | 37.6% | 21.4% | ||
| Q2 25 | 33.6% | 21.1% | ||
| Q1 25 | 28.8% | 23.4% | ||
| Q4 24 | — | 24.0% | ||
| Q3 24 | 25.2% | 20.9% | ||
| Q2 24 | 43.3% | 21.4% |
| Q1 26 | 40.8% | — | ||
| Q4 25 | 32.4% | 14.3% | ||
| Q3 25 | 32.5% | 11.1% | ||
| Q2 25 | 28.7% | 11.5% | ||
| Q1 25 | 24.7% | 13.3% | ||
| Q4 24 | — | 13.8% | ||
| Q3 24 | 21.9% | 11.6% | ||
| Q2 24 | 35.5% | 11.4% |
| Q1 26 | $0.89 | — | ||
| Q4 25 | $0.69 | $1.13 | ||
| Q3 25 | $0.65 | $0.83 | ||
| Q2 25 | $0.55 | $0.86 | ||
| Q1 25 | $0.47 | $0.98 | ||
| Q4 24 | — | $1.02 | ||
| Q3 24 | $0.40 | $0.81 | ||
| Q2 24 | $0.77 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $243.6M |
| Total DebtLower is stronger | — | $5.1B |
| Stockholders' EquityBook value | $2.2B | $1.6B |
| Total Assets | $2.8B | $18.7B |
| Debt / EquityLower = less leverage | — | 3.10× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $988.5M | $243.6M | ||
| Q3 25 | $791.1M | $241.3M | ||
| Q2 25 | $1.0B | $255.4M | ||
| Q1 25 | $1.1B | $227.2M | ||
| Q4 24 | — | $218.8M | ||
| Q3 24 | $1.2B | $185.4M | ||
| Q2 24 | $1.0B | $184.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.1B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | — | $5.0B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | — | $4.8B | ||
| Q3 24 | — | $4.7B | ||
| Q2 24 | — | $4.7B |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $1.6B | ||
| Q3 25 | $2.0B | $1.6B | ||
| Q2 25 | $2.1B | $1.6B | ||
| Q1 25 | $2.2B | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $2.3B | $1.6B | ||
| Q2 24 | $2.1B | $1.5B |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $18.7B | ||
| Q3 25 | $2.7B | $18.4B | ||
| Q2 25 | $2.8B | $18.0B | ||
| Q1 25 | $2.9B | $17.3B | ||
| Q4 24 | — | $17.4B | ||
| Q3 24 | $3.0B | $17.4B | ||
| Q2 24 | $2.8B | $16.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.10× | ||
| Q3 25 | — | 3.17× | ||
| Q2 25 | — | 3.19× | ||
| Q1 25 | — | 2.87× | ||
| Q4 24 | — | 2.83× | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | — | 3.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $333.5M | $212.9M |
| Free Cash FlowOCF − Capex | $332.4M | $87.2M |
| FCF MarginFCF / Revenue | 55.5% | 7.8% |
| Capex IntensityCapex / Revenue | 0.2% | 11.3% |
| Cash ConversionOCF / Net Profit | 1.36× | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $875.8M | $554.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $333.5M | — | ||
| Q4 25 | $290.3M | $212.9M | ||
| Q3 25 | $49.0M | $252.3M | ||
| Q2 25 | $211.4M | $166.4M | ||
| Q1 25 | $240.3M | $311.1M | ||
| Q4 24 | — | $264.1M | ||
| Q3 24 | $271.3M | $263.8M | ||
| Q2 24 | $119.5M | $196.9M |
| Q1 26 | $332.4M | — | ||
| Q4 25 | $288.8M | $87.2M | ||
| Q3 25 | $46.2M | $150.7M | ||
| Q2 25 | $208.5M | $83.4M | ||
| Q1 25 | $236.3M | $233.0M | ||
| Q4 24 | — | $151.8M | ||
| Q3 24 | $263.1M | $162.8M | ||
| Q2 24 | $113.0M | $100.8M |
| Q1 26 | 55.5% | — | ||
| Q4 25 | 48.3% | 7.8% | ||
| Q3 25 | 8.1% | 14.2% | ||
| Q2 25 | 37.5% | 7.8% | ||
| Q1 25 | 41.7% | 21.7% | ||
| Q4 24 | — | 13.9% | ||
| Q3 24 | 48.8% | 16.1% | ||
| Q2 24 | 17.7% | 9.7% |
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | 11.3% | ||
| Q3 25 | 0.5% | 9.6% | ||
| Q2 25 | 0.5% | 7.8% | ||
| Q1 25 | 0.7% | 7.3% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | 1.5% | 10.0% | ||
| Q2 24 | 1.0% | 9.3% |
| Q1 26 | 1.36× | — | ||
| Q4 25 | 1.50× | 1.34× | ||
| Q3 25 | 0.27× | 2.15× | ||
| Q2 25 | 1.32× | 1.35× | ||
| Q1 25 | 1.72× | 2.18× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | 2.30× | 2.24× | ||
| Q2 24 | 0.53× | 1.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXEL
| Cabometyx | $544.7M | 91% |
| Collaboration | $52.1M | 9% |
| Collaborative Arrangementwith Takeda | $5.9M | 1% |
| Cometriq | $1.8M | 0% |
SCI
| Cemetery | $510.9M | 46% |
| Funeral Matured Preneed Revenue | $196.5M | 18% |
| Cemetery Recognized Preneed Merchandise And Service Revenue | $107.4M | 10% |
| Cemetery Atneed Revenue | $104.9M | 9% |
| CA | $56.4M | 5% |
| Funeral Other Revenue | $54.6M | 5% |
| Cemetery Other Revenue | $40.2M | 4% |
| Nonfuneral Home Revenue | $28.1M | 3% |
| Non Funeral Home Preneed Sales Revenue | $22.0M | 2% |
